<<
>>

Bovine Models

16.3.1 Long-term bovine MAP challenge model

Because of the chronic nature of paratubercu­losis, bovine infection models that examined in­oculated animals for long periods (>6 months) are common (Table 16.3).

This long-term bovine model is typically used for studies of vaccination efficacy, preventive or therapeutic interventions, long-term pathogenesis, the immune response and assessment of diagnostic assays. A wide variety of MAP strains has been used in experi­mental infections (Table 16.3). Many reports identify strains only as ‘M. johnei,, ‘field isolate' or ‘clinical isolate', while others provide more specific strain designations. Strain K-10 was se­lected by the AMSC as the prototype strain for bovine infection models because it is known to be pathogenic and has a well-characterized gen­otype. However, the laboratory passage status of the K-10 MAP strain is currently unknown. Other low-passage virulent strains with a similar
Table 16.2. Main features of the murine and leporid (rabbit) models of paratuberculosis.
Model Murine Leporid (rabbit)
Breeds C57/BL6, BALB/c, SCID C3H, Beige, Swiss Albino White New Zealand
Route of administration Oral, intraperitoneal Oral
Infectious dose 107-108 CFU/animal 105-109 CFU/animal
Sample collection Liver, spleen, intestine, lymph nodes, sera Liver, spleen, intestine, lymph nodes, sera
Diarrhoea Never Frequent
Faecal shedding Rarely Occasionally
Experimental endpoints CFU count, histopathology, immunological evaluations CFU count, histopathology, clinical signs
Shortcomings Rare development of clinical signs of paratuberculosis Lack of reagents, incomplete clinical signs of paratuberculosis

CFU, colony-forming units; IT, Intratonsillar; SC, Subcutaneous; ATCC, American Type Culture Collection; IFN, Interferon; LBT, Lymphocyte blastogenesis test; IL, Interleukin.

short-segment repeat genotype (e.g. 15g-5ggt genotype; Ghadiali et al. (2004)) or equivalent pulsed-field gel electrophoresis or amplified fragment-length polymorphism genotype may also be used (Hines et al., 2007b). This allows use of various local MAP strains and minimizes regulatory issues concerning the import of in­fectious organisms.

Types of inocula that have been ad­ministered include faeces from an infected animal, intestinal mucosal scrapings, lymph node homogenates or in vitro-cultured MAP (Table 16.3). In previous studies, MAP has been harvested from solid media (Herrold's egg yolk, Middlebrook 7H11, Middlebrook 7H10, Taylor's, Dubos) or from broth (Middlebrook 7H9). Inocula prepared from homogenized in­testinal tissue, lymphoid tissue or faeces have been used, but these are difficult to standardize and aliquot for numerous studies. To address these issues, the AMSC has suggested that the chosen strain of MAP should be propagated in vitro from a master seed stock to mid-log-phase growth. Middlebrook 7H9 broth, supplemented with Oleic AlbuminDextrose Catalase (OADC), mycobactin J and 1% glycerol, was recommend­ed as the culture medium (Hines et al., 2007b).

Storage of the inoculum at 4°C beyond 4 weeks may result in reduced viability (R. Whitlock, Philadelphia, 2008, personal com­munication) but storage up to 2 weeks at 4°C is generally considered acceptable. However, it is recommended that the stored inoculum should be incubated at 3 7°C for 2-3 h prior to admin­istration. All samples within a study should be treated in the same manner.

Oral, intragastric and parenteral routes of inoculation have been successfully used (Table 16.3). However, the oral route is rec­ommended by the AMSC as this most closely mimics natural exposure and allows MAP uptake by tonsillar tissue as well as the intes­tinal tract. The calf is induced to suckle from a syringe containing MAP mixed with a small volume of milk replacer or pasteurized milk. The mixture can also be gently expressed over the back of the tongue to induce swallowing.

Administration by gastric tube is not recom­mended (Hines et al., 2007b).

Published doses range from 10-200 mg wet weight and 106 to 1011 CFU (Table 16.3) but were not based on standardized procedures. Doses of 5 ? 108 CFU given on 2 consecutive days reliably resulted in infection in calves by 12-14 weeks post-inoculation (Sweeney et al., 2006). The AMSC recommends use of a stand­ard bovine challenge dose of approximately 109 CFU/dose (100 mg wet weight) given on each of 2 successive days. Quantification of CFU should be by serial dilution and plating on solid medium known to support the organism without added antibiotics. Excessively large doses that produce clinical disease in cattle less than 18 months post-inoculation should be

Table 16.3. Bovine models for Mycobacterium avium subsp. paratuberculosis (MAP) infection.

A.M. Talaat eta∕.

Continued

ãî σ>

Table 16.3. Continued

A.M. Talaat eta∕.

aND = not determined.

bNR = not reported.

AGID1 agargel immunodiffusion test; CFT1CompIementfixation test; CIE1 crossed Immunoelectrophoresis; FLOW,flow cytometry; NOX1 nitric oxide; PI, post-inoculation; SEM,scanning electron microscopy; ÒÅÌ, transmission electron microscopy; ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction.

avoided as they are not typical in naturally oc­curring paratuberculosis (Hines et al., 2007b).

Previous studies reported challenge of cat­tle from 1 day of age to adulthood (Table 16.3).

While studies have suggested age-associated re­duction in susceptibility (Hagan, 1938; Doyle, 1953, 1956; ; Larsen et al., 19 75), a definitive relationship between infectious dose and age has not been established yet. Some flexibility in age of inoculation is required due to differences in experimental objectives and timing of other interventions, such as vaccination. Although some have suggested breed differences in suscep­tibility to infection (e.g. increased susceptibility of Jersey cattle to natural infection; Koets et al., 2000), this has not been formally evaluated in an experimental infection study. However, be­cause of the difference in clinical presentation of paratuberculosis in Bos indicus breeds, the AMSC recommends that Bos taurus breeds be used exclusively for studies of bovine paratuber­culosis (Hines et al., 2007b). Current experience suggests that 100 mg pelleted wet weight on 2 successive days results in demonstrable infection in calves less than 8 weeks of age (Hines et al., 2007b).

Current diagnostic methods are ineffec­tive for screening of individual calves at or be­fore 8 weeks of age. Calves should be purchased from paratuberculosis-free farms to ensure lack of prior exposure. In the USA, herds that have achieved the equivalent of Status Level 3 or 4 in the National Voluntary Bovine Johne's Disease Status Control Program should be chosen as source herds (Hines et al., 2007b; Usda-Aphis, 2010). This equates to a closed herd with no his­tory of paratuberculosis in the previous 5 years, tested annually with at least one whole-herd negative serological test and one whole-herd negative faecal test (second lactation and older animals).

Calves should have received adequate quantities of colostrum. Milk replacer, if used, should be high quality and of animal origin (i.e. casein not soy protein) and high-quality rations should be fed. Routine vaccinations may be ad­ministered but should not be given on the same days as paratuberculosis vaccination or MAP administration.

Anthelmintics and parasiticides should be given to all animals at normal dos­ages. If individual therapy is necessary (i.e. res­piratory infection), an antibiotic known to have minimal effects on MAP (i.e. ceftiofur) should be used.

Passive (pass-through) shedding occurs as early as 12 h after oral inoculation. Detection of passive shedding by culture provides addi­tional confirmation of inoculum viability and the sensitivity of the faecal culture method. Positive faecal culture results more than 14 days after inoculation should be considered shedding due to infection, except in very heav­ily contaminated environments (R. Whitlock, Philadelphia, 2008, personal communica­tion). The AMSC recommends that animals should have faecal cultures at least monthly during the course of the study. Gross exami­nation and culture of tissues for MAP as well as histopathological examination of tissues to identify acid-fast organisms and lesions char­acteristic of paratuberculosis should be per­formed in all studies. At the inoculation dose recommended, colonization of tissues can be detected by culture in most animals by 4-12 weeks after inoculation, although culture of multiple tissues (minimum of three ileum in­cluding ileocaecal valve, three jejunum, one duodenum, one spiral colon and three mesen­teric lymph nodes including ileocaecal nodes) is necessary. Although tissue samples should be culture-positive by 12 weeks, investigators should not always expect to find histologi­cal lesions at this early stage. A necropsy and histopathology scoring system should be used (Gonzalez etal., 2005; Hines etal., 2007b). The clinical status of the study animals should, at a minimum, be assessed and recorded monthly and at necropsy (Hines et al., 2007b).

The method of culturing faecal and tissue samples should permit quantification (or at least semi-quantification, e.g. by counting CFU on sol­id medium or time to positive detection in auto­mated liquid culture systems). Decontamination by incubation of faecal and tissue samples in 0.6% hexadecyl pyridinium chloride (HPC) for 14-16 h and 3 h, respectively, is strongly rec­ommended (Hines et al., 2007b).

There is wide variation in culture methods currently used and batch-to-batch differences occur in media. All samples should be processed on medium from the same batch. Fresh samples may be processed immediately or frozen at -70°C and thawed only once, with all samples treated in the same manner.

16.3.2 Short-term bovine MAP challenge models

Experimental MAP infection models that em­ploy direct surgical access to the ileum for ad­ministration of MAP and collection of intestinal samples have been described (Allen et al., 2005, 2009). In general, these models are most use­ful for short-term study of host-pathogen in­teractions. The time frame of such studies can vary from a few hours to a few days or even a few weeks (Wu et al., 2007a). Many parameters should be the same as for long-term challenge, including strain, inoculum preparation and quantification, storage, animal selection criteria and quality control issues. Exceptions are age of administration, dose, experimental endpoints and sample collection.

Ileal cannulation model

In this model, calves are cannulated at 8 weeks of age under general anaesthesia, us­ing a modification of the method of Streeter et al. (1991), as previously described (Hines et al., 2007b; Allen et al., 2009). Calves are in­oculated in the ileum with 1010 CFU of MAP in 20 ml phosphate-buffered saline. MAP is taken up by M cells and by dendritic and epi­thelial cells of the ileum and jejunum within 30 min (Momotani et al., 1988; SigurSardottir et al., 1999, 2001). The inoculation procedure is repeated the next day. Ileal mucosal biop­sies can be obtained at various time intervals, to test for MAP infection and local immune responses.

Invasion/surgical model

Surgical incision and direct deposition of MAP into the ileum has been recently employed to establish a model for intestinal invasion to other organs within a few hours of infection (Wu et al., 2007a). Although infected calves survive the surgery and repeated biopsy sam­pling up to 10 months following infection, the focus of this model is to examine early MAP intestinal interactions. The movement of MAP from intestine to liver, spleen or mes­enteric lymph node was shown to differentiate between MAP strains with different virulence phenotypes.

Intestinal loop model

An alternative surgical approach is the ligat­ed intestinal loop model with an injected in­oculum of 3 ? 109 CFU (~300mg wet weight) (Momotani et al., 1988; Khare et al., 2009). This is only suitable for studies related to bovine strain K-10, is recommended (Hines et al., 2007b).

The recommended method of inoculum preparation, quantification and storage is the same as stated above for the bovine model. The majority of studies used Middlebrook 7H9 + OADC + mycobactin J + glycerol or Tween 80 for in vitro cultivation. This medium with the addition of glycerol (1%), but without Tween or antibiotics, is considered to be the best choice (Hines et al., 2007b). The routes of administra­tion have varied (Table 16.4), and essentially all routes tested have been successful in establish­ing infection, with even the aerosol route result­ing in intestinal pathology (Harding, 1957). The oral route most closely parallels natural expo­sure and is generally considered the best route of administration.

The size of the challenge inoculum has also varied widely (Table 16.4), ranging from 2.3 7 to 200 mg and 3 ? 107 to 8 ? 1010 CFU, and all were generally successful in establishing infection. Two consecutive daily doses of 109 organisms (approximately 100 mg pelleted wet weight/dose and ~200 mg total dose) should establish infec­tion in most kids without overwhelming experi­mental interventions (Hines et al., 2007b).

The age at which to inoculate has var­ied from the day of birth to 10 months of age (Table 16.4). It is not known whether age-related resistance occurs in goats. The age of adminis­tration will depend on the experimental goals and endpoints, but generally the goats should be less than 4 months of age. Clinical disease is ex­pected to develop in a low percentage of animals at 9-10 months post-inoculation (Hines et al., 2007b).

The experimental endpoints will depend on the goals of the study. The minimal AMSC recommendations for goat experiments were to determine infection status through a com­bination of culture, PCR and histopathology, using quantitative or semi-quantitative meth­ods (Hines et al., 2007a, b). A lesion grading system for gross and histopathological findings (Hines et al., 2007a, b) should be used, with a sufficient range in values to allow statistical analysis. Recommendations for methods of faecal and tissue MAP culture and for sample handling are the same as for the bovine model. Like cattle, positive faecal cultures within 2 weeks or more post-inoculation should be con­sidered to be due to infection. Faecal cultures/ PCR should be performed at least monthly from all animals.

16.4.2 Short-term caprine MAP challenge models

In general, these models are used for short-term study of host-pathogen interactions. Many pa­rameters should be the same as for long-term challenge, including strain, inoculum prepara­tion and quantification, storage, animal selec­tion criteria and quality control issues.

Intestinal loop model

An intestinal loop model, as previously described in goats by SigurSardottir et al. (2001), can be used for studying initial paratuberculosis bac­terial-host interactions including bacterial attachment and internalization, bacterial locali­zation, cytokine regulation and early bacterial gene regulation. MAP strain, dose, quantifica­tion, culture medium, animal selection and sam­ple collection should be similar to the long-term challenge model (Hines et al., 2007b). Strain se­lection and quantification, animal selection and sample collection should also be similar to those for the long-term challenge model.

Table 16.4. Caprine models for Mycobacterium avium subsp. paratuberculosis (MAP) infection.

bgcolor=white>35 months
Reference Age at start MAP strain Dose(s) Infection method Study length Clinical disease Faecal culture Tissue culture Immune testing Histopathology
Harding, 1957 NRa NRa NRa IH

IV IV/oral oral

9-16 months NRa NDb 17/24 NDb 23/24
Van Kruiningen

et al., 1986

2-12 days Human isolate Linda 3.2?107

4.0?108

50 mg wst wt

Oral (milk) Upto 310 days No 1/4 4/4 NDb 4/4
SigurSardottir

et al., 1999

7-26 days Clinical goat isolate (three passages) 10mg dry wt

1 ? 10 days

Oral (milk) Up to 49 weeks No 0/8 2/8 Skin test +

ELISA +

CFT +

3/8
SigurSardottir

etal., 2001

18-21 days Clinical goat isolate 2.365 mg dry wt∕3ml four loops Distal ileal ligation 1 h No NDb NDb NDb MAP in M cells and leucocytes
SigurSardottir

etal., 2001

23-39 days ATCC bovine strain 19,698 Three? 107 per sleeve Everted intestine sleeve 1 h No NDb NDb NDb MAP uptake by M cells and enterocytes
Storset et al., 2001 5-8 weeks Clinical goat isolate (P173) two passages 10mg

three? 1 0 weeks

Oral (milk) Upto 117 weeks Yes 4/7 5/7 IFN-γ +

LBT +

ELISA +

6/7
Valheim et al., 2002 5-8 weeks Clinical goat isolate (P173) two passages 10mg

three? 1 0 weeks

Oral (milk) Upto 117 weeks Yes NDb 5/7 NDb 6/7
Munjal et al.,

2005

5-8 weeks Clinical goat isolate (tissue) 1 ?101° seven ? 2 days Oral Upto 270 days Yes 1/10 2/10 (PCR) LBT + ELISA + AGID + 5/10
Stewart et al., 2006 5 months Clinical bovine isolate (tissue/ culture) 1 ?101°

20 g wet wt

Oral 54 months Yes 10/10 8 IFN-γ + ELISA + NRa
Stewart et al., 2006 10 months Clinical sheep isolate (tissue/ One? 4 weeks Oral Yes 9/10 1 IFN-γ + ELISA + NRa

culture)

A.M. Talaat et al.

aNR = not reported.

bND = not determined.

ELISA, enzyme-linked immunosorbent assay; PCR1 polymerase chain reaction; TNF1 tumour necrosis factor; TGF1 tumour growth factor; CFU1 colony-forming units; AGID1 agar gel immunodiffusion test; OFT, complement fixation test; LBT1 lymphocyte blastogenesis test; ATCC, American Type Culture Collection; IFN, Interferon; LBT, Lymphocyte blastogenesis test; FLOW, Flow cytometry; IL, Interleukin.

Everted intestine sleeve model

An everted intestine sleeve model, as described by SigurSardottir et al. (2005), is also useful for stud­ying initial host-bacterial interactions, such as bacterial attachment and internalization, bacteri­al localization and early bacterial gene regulation, but may have limitations when evaluating host gene and early cytokine regulation in response to infection. Approximately 1.0-cm segments of small intestine are excised, everted, washed, main­tained in tissue culture and bathed in a suspension of MAP for short periods of time. Strain selection and quantification, animal selection and sample collection should be similar to those for the long­term challenge model.

16.5

<< | >>
Source: Behr Marcel A., Stevenson K., Kapur V. (eds.). Paratuberculosis: Organism, Disease, Control. 2nd edition. — CAB International,2020. — 439 p.. 2020
More medical literature on Medic.Studio

More on the topic Bovine Models:

  1. Bovine Tuberculosis
  2. BOVINE VIRAL DIARRHOEA
  3. Bovine Tuberculosis in Zambian Wildlife
  4. Bovine Tuberculosis Control Programs in South Africa
  5. Bovine TB Eradication Scheme
  6. Rodent Models
  7. Comparative Genotyping of Human and Bovine-Derived MAP Isolates
  8. Vaccine Models
  9. 8.3 Bovine Tuberculosis in African Cattle Populations
  10. 3. Models and definitions
  11. Cervid Models
  12. Competition in other 2-consumer-l-resource models
  13. Bovine TB in Ethiopia
  14. Lottery and neutral models rely on equality and chance
  15. A brief guide to externalities in growth models